Victoria Knight

Washington, D.C.

health care reporter @axios & an occasional Capitol food critic. past: @kffhealthnews. alum: @utknoxville & @universityofga. email: [email protected]

Featured in: Favicon

axios.com

bbc.co.uk

cnn.com

msn.com

washingtonpost.com Favicon

time.com

usatoday.com Favicon

webmd.com

yahoo.com (+2) Favicon

go.com + 100 more

Articles

House E&C eyes May 7 reconciliation markup

1 week ago | axios.com | Victoria Knight
States eye 340B changes with Congress stalled

1 week ago | axios.com | Victoria Knight

At least 15 states have taken up proposals to set new guardrails for the 340B discount drug program this year, with Congress still gridlocked on overhaul measures. Why it matters: Legislators say there's a need to ensure that low-income patients benefit from a safety net program that's been mired in litigation, with drugmakers, hospitals and other providers accusing one another of gaming the system.
Axios Pro tracker: Health care bills to watch

2 weeks ago | axios.com | Peter Sullivan |Victoria Knight

We're back with a fresh bill tracker for the new Congress. Why it matters: Other than reconciliation and possible Medicaid changes, not a lot is moving on health care front at the moment after the demise of December's health package. Here's what is still on the table:Medicaid cutsThe issue: Medicaid cut proposals include per capita caps on spending, lowering the federal share of costs (FMAP) for the expansion population, and imposing work requirements and doing stricter eligibility checks.
House clears budget hurdle with Medicaid fight ahead

2 weeks ago | axios.com | Peter Sullivan |Victoria Knight

The House cleared a major hurdle Thursday with the adoption of Senate amendments to its budget resolution, but competing promises to different groups of lawmakers mean key decisions on Medicaid lie ahead. Why it matters: A resolution calling for $1.5 trillion in cuts puts a target on the safety net program, but it's unclear how big the bullseye is.
E&C staff to meet with HHS counterparts over cuts

2 weeks ago | axios.com | Victoria Knight

Republican and Democratic staff on the House Energy and Commerce Committee are due to meet withHHS staff Friday to air concerns over the sweeping reorganization and job cuts at the department. Why it matters: E&C Democrats have been demanding a meeting with Secretary Robert F. Kennedy Jr., but the meeting will be the first chance to convey grievances directly to agency staffover DOGE-directed cuts and upheaval at agencies including NIH and the FDA.
Medicare GLP-1 coverage back in Congress' hands

2 weeks ago | axios.com | Victoria Knight

Congress may be back on the hook for deciding whether Medicare should pay for GLP-1s and other anti-obesity drugs after the Trump administration kept a longstanding coverage prohibition in a 2026 Medicare payment rule. But the price tag doesn't bode well for an immediate revival of the Treat and Reduce Obesity Act. Why it matters: Expanding coverage to the blockbuster drugs would be politically popular but would carry a cost of perhaps $35 billion through 2034.
First look: Dems fear rollback of VA abortion rule

2 weeks ago | axios.com | Victoria Knight
Senate sets up clash over Medicaid cuts

2 weeks ago | axios.com | Victoria Knight |Peter Sullivan
Senate Judiciary revives drug patent reform efforts

3 weeks ago | axios.com | Victoria Knight

The Senate Judiciary Committee on Thursday advanced a half-dozen bills addressing drug pricing, some of which would overhaul the patent system to take aim at industry practices that critics blame for delayingcompetition from generics. Why it matters: The near-unanimous bipartisan support shows that momentum remains in the Senate for using patent system changes to address high pharmaceutical costs.
First look: Trump is urged to keep drug negotiations

3 weeks ago | axios.com | Victoria Knight

Patients for Affordable Drugs is launching an ad campaign Thursday that asks President Trump to maintain Democrats' Medicare drug price negotiation process. Why it matters: The administration has signaled that it will defend the negotiations but still could make changes to the program that accommodate the industry. State of play: The ad, shared first with Axios, splices clips of Trump talking about drug prices during his first term and bashing the pharmaceutical industry.